Mounjaro®
Starting from £179.99/mo
Start journey Learn moreYes, burping is a recognised side effect of Wegovy (semaglutide). It appears in the medicine's official prescribing information and is linked to the way semaglutide slows gastric emptying — food and gas move through your stomach more slowly than usual, and excess air finds its way up. For most people it is mild and tends to ease as the body adjusts. Because Wegovy is a prescription-only medicine, a GPhC-registered prescriber assesses your full health picture before treatment starts, which includes discussing the side effects you are most likely to notice.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
It catches a lot of people off guard. You start treatment, the nausea gets the most press, but it is the near-constant belching that becomes the thing you mention to your pharmacist. This is not unusual. Semaglutide works partly by slowing the rate at which your stomach empties into the small intestine, a mechanism that reduces appetite but also means gas accumulates before it has anywhere to go. The result, for a significant number of people, is noticeably more burping than normal, particularly in the first few weeks.
The full Wegovy side-effect profile is dominated by this gastrointestinal pattern. Nausea, burping, indigestion and reflux often travel together because they share the same root cause: a gut that is now working at a different pace. Burping on Wegovy on its own, without pain or vomiting, is uncomfortable rather than dangerous. That said, it is worth understanding when to ride it out and when to take it seriously, which is exactly what this page covers.
The NHS semaglutide medicines page lists belching among the common side effects of semaglutide treatment. Common in this context means it is reported by at least one in a hundred patients, in practice, the proportion is considerably higher among people on weight-management doses.
Gastric emptying slows because semaglutide acts on GLP-1 receptors in the gut wall, reducing the contractions that push food downward. When the stomach holds food longer, it also holds the gas that forms during digestion. Swallowed air (something most of us do more of when eating quickly or drinking fizzy drinks) has even less opportunity to disperse quietly.
A few patterns consistently make burping worse on semaglutide. Eating too quickly is the biggest one; the stomach is already working slowly, and piling food in faster than it can handle amplifies the pressure. Carbonated drinks are the second. Fatty or very rich meals slow emptying further on top of the drug's existing effect. Some people also notice it more first thing in the morning before anything has been eaten.
Practical adjustments that genuinely help: smaller meals taken more slowly, plain still water rather than sparkling, and leaving a gap of at least twenty minutes between courses if you are eating a larger meal. If you take Wegovy on a set day each week, you might find that the day after injection (when semaglutide levels are highest in the blood) is the day to keep food particularly light. Stored in the fridge door alongside your pen as a visual cue, a note about that lighter-meal day is the kind of small habit that makes a real difference.
There is more detail on how semaglutide specifically causes burping, including the mechanism behind gastric slowing, in our dedicated piece on the topic.
Most burping on Wegovy is exactly what it appears to be: an inconvenient but harmless consequence of slowed gastric emptying. It tends to peak in the first two to four weeks of a new dose and then improve significantly as the body adapts. Many people find it nearly disappears by the time they have been on a dose for six weeks.
There are circumstances, though, where upper gastrointestinal symptoms on semaglutide require prompt medical attention. Acute pancreatitis is a rare but serious side effect of GLP-1 medicines. In January 2026 the MHRA issued a Drug Safety Update specifically reminding healthcare professionals and patients about pancreatitis risk with this class of medicine. The warning sign is severe, persistent stomach pain, not the dull bloat of trapped wind, but intense pain that does not pass and may radiate toward the back, sometimes accompanied by vomiting. If you experience this, stop eating and get medical help the same day. Do not wait it out.
Other symptoms worth reporting promptly include signs of significant dehydration from repeated vomiting or diarrhoea, an allergic reaction (swelling around the face, throat tightening, rash), or yellowing of the skin or whites of the eyes, which can indicate a gallbladder problem. Gallbladder issues are more common in people losing weight rapidly, and Wegovy is associated with this in a small number of cases. Some people also notice changes in their stools, and if you are concerned about yellow diarrhea while taking Wegovy, our dedicated page explains what can cause it and when to seek advice.
If burping is accompanied by persistent heartburn or acid reflux that is not settling, speak to your prescriber rather than managing it alone, adjusting the dose timing or slowing titration can sometimes resolve this. You can also report suspected side effects directly to the MHRA via the Yellow Card scheme, which helps build the safety picture for medicines like Wegovy.
The reassuring news is that for the vast majority of people, burping settles. It is dose-sensitive, which means it often returns briefly each time the dose goes up, then fades again. By the time people reach their maintenance dose, many report it as a non-issue.
What matters is having a prescriber who takes these conversations seriously at every stage of treatment, not just at the start. At nume, a named clinician reviews your situation before each repeat, not as a formality, but because side effects at one dose inform whether and how quickly to move to the next. Our clinical team treats aftercare as part of the service, seven days a week.
If you are weighing up the side-effect profile more broadly before starting, the Wegovy overview page covers how the treatment works, what it is licensed for, and what the clinical trial evidence shows. Or if cost is a factor in your thinking, the Wegovy pricing page sets out what private treatment typically includes and what to look for when comparing providers.
Wegovy is a prescription-only medicine and a prescriber decides clinical suitability. If you would like to discuss whether treatment is appropriate for you, including how side effects are managed, you can check your eligibility with our team today.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.